| Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes KM Champion, JGR Gilbert, FA Asimakopoulos, S Hinshelwood, ... British journal of haematology 97 (4), 920-926, 1997 | 210 | 1997 |
| Autologous transplantation for newly diagnosed multiple myeloma in the era of novel agent induction: a systematic review and meta-analysis B Dhakal, A Szabo, S Chhabra, M Hamadani, A D’Souza, SZ Usmani, ... JAMA oncology 4 (3), 343-350, 2018 | 184 | 2018 |
| Immunoregulatory roles of versican proteolysis in the myeloma microenvironment C Hope, S Foulcer, J Jagodinsky, SX Chen, JL Jensen, S Patel, C Leith, ... Blood, The Journal of the American Society of Hematology 128 (5), 680-685, 2016 | 152 | 2016 |
| Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers MU Mushtaq, A Papadas, A Pagenkopf, E Flietner, Z Morrow, ... Journal for immunotherapy of cancer 6, 1-14, 2018 | 145 | 2018 |
| Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells J Kim, RA Denu, BA Dollar, LE Escalante, JP Kuether, NS Callander, ... British journal of haematology 158 (3), 336-346, 2012 | 143 | 2012 |
| ABL1 Methylation Is a Distinct Molecular Event Associated With Clonal Evolution of Chronic Myeloid Leukemia FA Asimakopoulos, PJ Shteper, S Krichevsky, E Fibach, A Polliack, ... Blood, The Journal of the American Society of Hematology 94 (7), 2452-2460, 1999 | 136 | 1999 |
| Deletions of chromosome 20q and the pathogenesis of myeloproliferative disorders FA Aimakopoulos, AR Green British journal of haematology 95 (2), 219-226, 1996 | 117 | 1996 |
| Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromes FA Asimakopoulos, NJ White, E Nacheva, AR Green | 112 | 1994 |
| TPL2 kinase regulates the inflammatory milieu of the myeloma niche C Hope, SJ Ollar, E Heninger, E Hebron, JL Jensen, J Kim, I Maroulakou, ... Blood, The Journal of the American Society of Hematology 123 (21), 3305-3315, 2014 | 111 | 2014 |
| Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B cells NJ White, E Nacheva, FA Asimakopoulos, D Bloxham, B Paul, AR Green | 111 | 1994 |
| Versican-derived matrikines regulate Batf3–dendritic cell differentiation and promote T cell infiltration in colorectal cancer C Hope, PB Emmerich, A Papadas, A Pagenkopf, KA Matkowskyj, ... The Journal of Immunology 199 (5), 1933-1941, 2017 | 109 | 2017 |
| Loss of SIRT3 provides growth advantage for B cell malignancies W Yu, RA Denu, KA Krautkramer, KM Grindle, DT Yang, F Asimakopoulos, ... Journal of Biological Chemistry 291 (7), 3268-3279, 2016 | 92 | 2016 |
| LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis SD Ma, X Xu, J Plowshay, EA Ranheim, WJ Burlingham, JL Jensen, ... The Journal of clinical investigation 125 (1), 304-315, 2015 | 74 | 2015 |
| The gene encoding hematopoietic cell phosphatase (SHP-1) is structurally and transcriptionally intact in polycythemia vera FA Asimakopoulos, S Hinshelwood, JGR Gilbert, CC Delibrias, ... Oncogene 14 (10), 1215-1222, 1997 | 71 | 1997 |
| Interstitial deletion constitutes the major mechanism for loss of heterozygosity on chromosome 20q in polycythemia vera FA Asimakopoulos, JG Gilbert, MA Aldred, TC Pearson, AR Green | 69 | 1996 |
| Versican and versican-matrikines in cancer progression, inflammation, and immunity A Papadas, G Arauz, A Cicala, J Wiesner, F Asimakopoulos Journal of Histochemistry & Cytochemistry 68 (12), 871-885, 2020 | 64 | 2020 |
| Macrophages in multiple myeloma: emerging concepts and therapeutic implications F Asimakopoulos, J Kim, RA Denu, C Hope, JL Jensen, SJ Ollar, ... Leukemia & lymphoma 54 (10), 2112-2121, 2013 | 64 | 2013 |
| Single-molecule analysis reveals widespread structural variation in multiple myeloma A Gupta, M Place, S Goldstein, D Sarkar, S Zhou, K Potamousis, J Kim, ... Proceedings of the National Academy of Sciences 112 (25), 7689-7694, 2015 | 61 | 2015 |
| A detailed physical and transcriptional map of the region of chromosome 20 that is deleted in myeloproliferative disorders and refinement of the common deleted region AJ Bench, MA Aldred, SJ Humphray, KM Champion, JGR Gilbert, ... Genomics 49 (3), 351-362, 1998 | 58 | 1998 |
| Detection of chromosome 20q deletions in bone marrow metaphases but not peripheral blood granulocytes in patients with myeloproliferative disorders or myelodysplastic syndromes FA Asimakopoulos, TL Holloway, EP Nacheva, MA Scott, P Fenaux, ... | 58 | 1996 |
